Chinese Public Payer Data Show More New Drugs Get Faster Coverage

But Pricing Trade-Off

 
• By Dexter Jie Yan
  
NHSA spending on novel drugs
China's public payer spends more on novel drugs but their share of total health expense rose only slowly • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia